| 2023: The year in cardiovascular disease–the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024? M Banach, S Surma, PP Toth Archives of Medical Science: AMS 19 (6), 1602, 2023 | 18 | 2023 |
| A Journal on Psychiatry, Psychology and Psychopharmacology I CASELLI, N POLONI, M IELMINI, M MATTIA, A DE LEO, M DI SARNO, ... Minerva Psichiatrica 60 (3), 114-23, 2019 | | 2019 |
| A look to the past–what has had the biggest impact on lipids in the last four decades? A personal perspective M Banach, S Surma Archives of Medical Science: AMS 19 (3), 559, 2023 | 21 | 2023 |
| Acute Coronary Syndrome: Destabilization of Atherosclerotic Plaque in COVID-19 (Epidemiology, Influence on Prognosis, Pathogenesis, and Treatment) S Surma, J Lewek, M Banach Cardiovascular Complications of COVID-19: Acute and Long-Term Impacts, 121-150, 2023 | | 2023 |
| Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment M Adamczak, S Surma, A Więcek Advances in Clinical and Experimental Medicine 31 (3), 317-326, 2022 | 34 | 2022 |
| Alcohol and Atrial Fibrillation S Surma, GYH Lip Reviews in Cardiovascular Medicine 24 (3), 73, 2023 | 2 | 2023 |
| Alcohol and health. Is regular drinking of small doses of alcohol really good for your health? S Surma, A Więcek Archives of medical sciences. Atherosclerotic diseases 7, e49, 2022 | 4 | 2022 |
| Alcohol, health loss, and mortality: can wine really save the good name of moderate alcohol consumption? S Surma, G Gajos Polish archives of internal medicine 134 (4), 16708, 2024 | 1 | 2024 |
| Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia S Surma, M Romańczyk, KJ Filipiak Cardiology Journal 30 (1), 131-142, 2023 | 19 | 2023 |
| Assessment of psychiatric rehabilitation by patients hospitalized in forensic psychiatry departments J Fojcik, M Romańczyk, S Surma, I Krupka Matuszczyk, M Krzystanek Psychiatria, Published online, 2021 | 1 | 2021 |
| Assessment of the effect of A-prf application during the surgical extraction of third molars on healing and the concentration of C-reactive protein JM Nowak, S Surma, M Romańczyk, A Wojtowicz, KJ Filipiak, ... Pharmaceutics 13 (9), 1471, 2021 | 11 | 2021 |
| Assessment the awareness toward hypertension and diabetes mellitus: Syrian cross sectional study S Swed, H Alibrahim, H Bohsas, W Hafez, S Surma, MA Rais, ... BMC Public Health 23 (1), 789, 2023 | 2 | 2023 |
| Association of Body Mass Index with Outcomes in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) M Czapla, S Surma, A Kwaśny, Ł Lewandowski Nutrients 16 (15), 2473, 2024 | | 2024 |
| Awareness of selected risk factors for cardiovascular disease in the young population S Surma, A Szyndler, K Narkiewicz Article in Polish]. Choroby Serca i Naczyń 14 (4), 186, 2017 | 6 | 2017 |
| Breaking New Ground in Lipid Management: Insights from the 2024 American College of Cardiology Scientific Sessions S Surma, MD Shapiro, M Banach Pharmacological research, 107246, 2024 | | 2024 |
| Celebrating the 90th birthday of the scientist who discovered statins: Akira Endō S Surma, DP Mikhailidis, M Banach European Heart Journal 45 (9), 647-650, 2024 | 1 | 2024 |
| Coffee and arterial hypertension S Surma, S Oparil Current hypertension reports 23 (7), 38, 2021 | 60 | 2021 |
| Coffee and caffeine consumption and overall mortality. Pleasure with restrictions-where do we really stand in 2022? S Surma, M Banach Nutrition (Burbank, Los Angeles County, Calif.) 102, 111747, 2022 | 8 | 2022 |
| Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies S Surma, M Romańczyk, KJ Filipiak, GYH Lip Cardiology Journal 30 (4), 654-667, 2023 | 9 | 2023 |
| Coffee and lipid profile: from theory to everyday practice S Surma, M Romańczyk, MO Zembala, KJ Filipiak Folia Cardiologica 18 (1), 24-30, 2023 | 3 | 2023 |
Maciej BanachSecretary, European Atherosclerosis Society & President, International Lipid Expert Panel; Poland在 umed.lodz.pl 的电子邮件经过验证
